Ongoing pregnancy · women of reproductive age (15 to 49 years) seeking induced abortion
Self‐administered medical abortion showed no clear difference in ongoing pregnancy – RCTs ( compared with provider‐administered medical abortion (low certainty).
1 finding from 1 review
Any complication requiring surgical intervention ‐ NRSs ( · women of reproductive age (15 to 49 years) seeking induced abortion
The review found no eligible studies for this question.
2 findings from 1 review
Ongoing pregnancy ‐ NRSs ( · women of reproductive age (15 to 49 years) seeking induced abortion
It is very uncertain whether self‐administered medical abortion changes ongoing pregnancy ‐ NRSs ( compared with provider‐administered medical abortion (very low certainty).
1 finding from 1 review
Pain intensity VAS (0 to 100; 0 = no pain, 100 = worst pain) · Patients with acute low‐back pain
1 finding from 1 review
Return to work · Patients with acute low‐back pain
The review found no eligible studies for this question.
1 finding from 1 review
no estimate extracted
Studies not reported
No studies found
Disability RMDQ (0 to 24; lower = better) · Patients with acute low‐back pain
1 finding from 1 review
Proportion of participants experiencing global improvement % of dichotomized Likert scale · Patients with acute low‐back pain
NSAIDs may leads to higher proportion of participants experiencing global improvement Various… compared with placebo (low certainty).
1 finding from 1 review
Proportion of participants experiencing adverse events · Patients with acute low‐back pain
It is very uncertain whether NSAIDs changes proportion of participants experiencing adverse events compared with placebo (very low certainty).
1 finding from 1 review
Return to work · Patients with acute low‐back pain
It is very uncertain whether NSAIDs changes return to work (%) compared with placebo (very low certainty).
1 finding from 1 review
Change in pain intensity from baseline on VAS (0 to 100) short‐term · Patients with acute low‐back pain
1 finding from 1 review
Disability ODI (0 to 50; lower = better) · Patients with acute low‐back pain
1 finding from 1 review
Proportion of participants experiencing global improvement % of dichotomized Likert scale · Patients with acute low‐back pain
1 finding from 1 review
Proportion of participants experiencing adverse events · Patients with acute low‐back pain
It is very uncertain whether selective COX‐2 inhibitors changes proportion of participants experiencing adverse events compared with non‐selective NSAIDs (very low certainty).
1 finding from 1 review
Urinary continence within 1 week after catheter removal MCID: 5% absolute difference · men (ages > 18 years) with clinically localized prostate cancer
Retzius‐sparing RALP probably leads to higher urinary continence within 1 week after catheter removal MCID: 5%… compared with standard RALP (moderate certainty).
1 finding from 1 review
Urinary continence 3 months after surgery MCID: 5% absolute difference · men (ages > 18 years) with clinically localized prostate cancer
Retzius‐sparing RALP may leads to higher urinary continence 3 months after surgery MCID: 5% absolute difference compared with standard RALP (low certainty).
1 finding from 1 review
Serious adverse events · men (ages > 18 years) with clinically localized prostate cancer
It is very uncertain whether retzius‐sparing RALP changes serious adverse events compared with standard RALP (very low certainty).
1 finding from 1 review
Urinary continence 12 months after surgery MCID: 5% absolute difference · men (ages > 18 years) with clinically localized prostate cancer
Retzius‐sparing RALP showed no clear difference in urinary continence 12 months after surgery MCID: 5% absolute… compared with standard RALP (moderate certainty).
1 finding from 1 review
Potency 12 months after surgery MCID: 5% absolute difference · men (ages > 18 years) with clinically localized prostate cancer
It is very uncertain whether retzius‐sparing RALP changes potency 12 months after surgery MCID: 5% absolute difference compared with standard RALP (very low certainty).
1 finding from 1 review
Positive surgical margins MCID: 5% absolute difference · men (ages > 18 years) with clinically localized prostate cancer
Retzius‐sparing RALP may leads to higher positive surgical margins MCID: 5% absolute difference compared with standard RALP (low certainty).
1 finding from 1 review
Biochemical recurrence‐free survival · men (ages > 18 years) with clinically localized prostate cancer
It is very uncertain whether retzius‐sparing RALP changes biochemical recurrence‐free survival compared with standard RALP (very low certainty).
1 finding from 1 review